94 filings
Page 5 of 5
8-K
n4c4bm5we
11 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
cr2qmb
7 Feb 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ewh668wh69
4 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
neypnrgn0ip9b5
31 Jan 14
Other Events
12:00am
8-K
mifmk j50pm33595sh
10 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
clf1sby
10 Dec 13
Enanta Pharmaceuticals Announces 96 Percent SVR12 in Treatment Experienced Genotype 1 hepatitis C Patients in SAPPHIRE-II Study
12:00am
8-K
lqwsgsvsxtszse
26 Nov 13
Departure of Directors or Certain Officers
12:00am
8-K
8ls9g0 bfosk1l7m5
25 Nov 13
Results of Operations and Financial Condition
12:00am
8-K
g28iw1f9
18 Nov 13
Enanta Pharmaceuticals Announces 96 Percent SVR12 in SAPPHIRE-I Study
12:00am
8-K
3z4ed43d
3 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
guq0ptfbx
21 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
rzi3g2 bgmwcsk4d
12 Aug 13
Results of Operations and Financial Condition
12:00am
8-K
19bzwogbn n6
8 May 13
Results of Operations and Financial Condition
12:00am
8-K
dwdqq2bk
28 Mar 13
Amendments to Articles of Incorporation or Bylaws
12:00am